Publicacións en colaboración con investigadores/as de Corporació Sanitària Parc Taulí (3)

2024

  1. Cough severity visual analog scale scores and quality of life in patients with refractory or unexplained chronic cough

    Respiratory Investigation, Vol. 62, Núm. 6, pp. 987-994

2019

  1. Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 7, pp. 2277-2283.e2

2011

  1. Effects of omalizumab in Aspergillus-associated airway disease

    Thorax